Document Detail


Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
MedLine Citation:
PMID:  12415549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: It has been proposed that lithium may be clinically effective due to its actions on the phosphoinositol second messenger system (PI-cycle). Studies have also suggested that untreated manic patients may have raised myo-inositol and phosphomonoester (PME) concentrations and also that unmedicated euthymic bipolar patients may have lowered PME concentrations. The objective of the present study was to test the hypothesis that chronic treatment with either lithium or sodium valproate in patients with bipolar mood disorder leads to a normalization in the activity of the PI-cycle. METHODS: This study had two parts each with different MRS methodology. The first part compared healthy controls (n = 19) with euthymic bipolar patients who were taking either lithium (n = 16) or sodium valproate (n = 11) using both (1)H-MRS and (31)P-MRS. In the second part we examined a separate group of euthymic bipolar disorder patients taking sodium valproate (n = 9) and compared these with age and sex-matched healthy controls (n = 11) using (1)H-MRS. RESULTS: Both studies showed that there were no differences in either myo-inositol or phosphomonoester (PME) concentrations between controls and patients taking either medication. CONCLUSIONS: These findings examine two key components of the PI-cycle in treated euthymic bipolar (myo-inositol and PME concentrations). The results from this study are consistent with the suggestion that chronic treatment with either lithium or sodium valproate in bipolar patients may normalize PI-cycle functioning.
Authors:
Peter H Silverstone; Ren H Wu; Tina O'Donnell; Michele Ulrich; Sheila J Asghar; Christopher C Hanstock
Related Documents :
10418589 - Incidence, prognosis, and etiology of end-stage liver disease in patients receiving hom...
11100349 - Early use of cyclic tpn prevents further deterioration of liver functions for the tpn p...
21722709 - Pre-screening and follow-up of childhood acute leukemia using biochemical infrared anal...
3086659 - Utilization of parenterally administered glucose oligosaccharides when infused with glu...
6632019 - Thermal injury in an adrenalectomized patient.
2291429 - Anorexia/bulimia nervosa: the development of anorexia nervosa and of mental symptoms. t...
3427789 - Hyperprolactinaemia and microadenomas in primary hypothyroidism.
20497859 - Papillary fibroelastomas in 19 patients with hypertrophic cardiomyopathy undergoing sep...
10882649 - Immunological diagnosis of human hydatid cyst relapse: utility of the enzyme-linked imm...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Human psychopharmacology     Volume:  17     ISSN:  0885-6222     ISO Abbreviation:  Hum Psychopharmacol     Publication Date:  2002 Oct 
Date Detail:
Created Date:  2002-11-04     Completed Date:  2002-11-19     Revised Date:  2008-03-06    
Medline Journal Info:
Nlm Unique ID:  8702539     Medline TA:  Hum Psychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  321-7     Citation Subset:  IM    
Copyright Information:
Copyright 2002 John Wiley & Sons, Ltd.
Affiliation:
Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada. peter.silverstone@ualberta.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Algorithms
Antimanic Agents / therapeutic use*
Bipolar Disorder / drug therapy*,  metabolism
Brain Chemistry / drug effects
Female
Frontal Lobe / drug effects,  metabolism
Humans
Inositol / metabolism
Lithium / therapeutic use*
Magnetic Resonance Spectroscopy
Male
Phosphatidylinositols / metabolism*
Psychiatric Status Rating Scales
Temporal Lobe / drug effects,  metabolism
Valproic Acid / therapeutic use*
Chemical
Reg. No./Substance:
0/Antimanic Agents; 0/Phosphatidylinositols; 6917-35-7/Inositol; 7439-93-2/Lithium; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of volatile compounds in the headspace of aqueous liquids using selected ion flow tub...
Next Document:  The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label s...